Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Streptomyces collinus Tu 365 and Kutzneria sp. CA-103260 metabolomics data

ABSTRACT: This dataset was used to benchmark UmetaFlow, an untargeted metabolomics workflow for data processing and analysis. Preprint connected to data DOI: 10.26434/chemrxiv-2022-z0t4g

INSTRUMENT(S): Orbitrap ID-X, LC-MS-MS/MS

ORGANISM(S): Streptomyces Collinus Tu 365 (ncbitaxon:1214242) Kutzneria Sp. Ca-103260

SUBMITTER: Karl Tilmann Weber

PROVIDER: MSV000090048 | MassIVE | Mon Aug 01 04:05:00 BST 2022

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS - Streptomyces collinus Tu 365 and Kutzneria sp. CA-103260 metabolomics data

Project description:This dataset was used to benchmark UmetaFlow, an untargeted metabolomics workflow for data processing and analysis. Preprint connected to data DOI: 10.26434/chemrxiv-2022-z0t4g

2022-08-01 | MSV000090048 | GNPS

Large-scale Actinomycete metabolomic dataset UmetaFlow

Project description:>1000 raw files from actinomycete extracts. ISP2, DNPM, and FPY12 media were used to grow every strain (approximately 100 strains) and triplicates for every treatment. This dataset was used to build and test UmetaFlow, an untargeted metabolomics computational workflow for high-throughput processing and analysis. Not all data were deposited because of confidentiality. Preprint connected to data DOI: 10.26434/chemrxiv-2022-z0t4g

2022-10-19 | MSV000090553 | MassIVE

GNPS - Commercial standards of Streptomyces antibiotics

Project description:Commercial standards for 8 antibiotics produced by Streptomyces used for method validation for the untargeted metabolomics workflow UmetaFlow (Preprint connected to data DOI: 10.26434/chemrxiv-2022-z0t4g). Compounds: Germicidin A, Germicidin B, Kanamycin, Tetracycline, Thiostreptone, Globomycin, Ampicillin and Apramycin.

2022-08-01 | MSV000090047 | GNPS

Pyracrimycin A producer-strains

Project description:Data used for the validation of the untargeted metabolomics workflow UmetaFlow (Preprint DOI: 10.26434/chemrxiv-2022-z0t4g) and generated for the publication "Identification of the biosynthetic gene cluster for pyracrimycin A and elucidation of a key reaction during its biosynthesis" by Nielsen J. B. et al. (https://doi.org/10.1021/acschembio.2c00480)

2022-08-01 | MSV000090049 | MassIVE

GNPS - Large-scale Actinomycete metabolomic dataset UmetaFlow

2022-10-19 | MSV000090553 | GNPS

GNPS - Pyracrimycin A producer-strains

2022-08-01 | MSV000090049 | GNPS

Evolution of conserved noncoding sequences (CNS) in Arabidopsis thaliana

Project description:We report ATAC-seq for several A. thaliana accessions in healthy leaf tissue. As part of an investigation into the evolution of conserved noncoding sequences, our goal was to identify overlaps between regions of accessible chromatin and CNS. Manuscript in review. Biorxiv preprint doi: https://doi.org/10.1101/727669

2021-01-04 | GSE164159 | GEO

New Napyradiomycin Analogues from Streptomyces sp. Strain CA-271078.

Project description:As part of our continuing efforts to discover new bioactive compounds from microbial sources, a reinvestigation of extracts of scaled-up cultures of the marine-derived Streptomyces sp. strain CA-271078 resulted in the isolation and structural elucidation of four new napyradiomycins (1-3, 5). The known napyradiomycin SC (4), whose structural details had not been previously described in detail, and another ten related known compounds (6-15). The structures of the new napyradiomycins were characterized by HRMS and 1D- and 2D-NMR spectroscopies and their relative configurations were established through a combination of molecular modelling with nOe and coupling constants NMR analysis. The absolute configuration of each compound is also proposed based on biosynthetic arguments and the comparison of specific rotation data with those of related compounds. Among the new compounds, 1 was determined to be the first non-halogenated member of napyradiomycin A series containing a functionalized prenyl side chain, while 2-4 harbor in their structures the characteristic chloro-cyclohexane ring of the napyradiomycin B series. Remarkably, compound 5 displays an unprecedented 14-membered cyclic ether ring between the prenyl side chain and the chromophore, thus representing the first member of a new class of napyradiomycins that we have designated as napyradiomycin D1. Anti-infective and cytotoxic properties for all isolated compounds were evaluated against a set of pathogenic microorganisms and the HepG2 cell line, respectively. Among the new compounds, napyradiomycin D1 exhibited significant growth-inhibitory activity against methicillin-resistant Staphylococcus aureus, Mycobacterium tuberculosis, and HepG2.

| S-EPMC7024253 | biostudies-literature

Complete Genome Sequence of <i>Streptomyces</i> sp. Strain CA-256286.

Project description:Here, we report the sequencing, assembly, and annotation of the genome of Streptomyces sp. strain CA-256286. The genome consists of a linear 7,726,360-nucleotide chromosome and a linear 466,817-nucleotide putative plasmid. This strain is predicted to produce a range of novel secondary metabolites.

| S-EPMC8354538 | biostudies-literature

MDN-0170, a New Napyradiomycin from Streptomyces sp. Strain CA-271078.

Project description:A new napyradiomycin, MDN-0170 (1), was isolated from the culture broth of the marine-derived actinomycete strain CA-271078, together with three known related compounds identified as 4-dehydro-4a-dechloronapyradiomycin A1 (2), napyradiomycin A1 (3) and 3-chloro-6,8-dihydroxy-8-?-lapachone (4). The structure of the new compound was determined using a combination of spectroscopic techniques, including 1D and 2D NMR and electrospray-time of flight mass spectrometry (ESI-TOF MS). The relative configuration of compound 1, which contains two independent stereoclusters, has been established by molecular modelling in combination with nOe and coupling constant analyses. Biosynthetic arguments also allowed us to propose its absolute stereochemistry. The antimicrobial properties of the compounds isolated were evaluated against methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, Aspergillus fumigatus, and Candida albicans. The potent bioactivity previously reported for compounds 2 and 3 against methicillin-sensitive S. aureus has been extended to methicillin-resistant strains in this report.

| S-EPMC5082336 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data